Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | DL32D | — |
several vaccines that were exposed to a below temperature excursion; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a elderly female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number DL32D) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced incorrect storage of drug (Verbatim: several vaccines that were exposed to a below temperature excursion). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date :15-MAY-2025 A registered nurse asked the recommendations after giving several vaccines that were exposed to a below temperature excursion of 29.9 degree Fahrenheit as the lowest reached for product which led to incorrect storage of drug. The vaccine administration facility was the same as primary reporter. No expiration date given for the vaccines nor date of administration. This was 1 of 5 linked cases, reported by same reporter different patient.; Sender's Comments: US-GSK-US2025061534:same reporter US-GSK-US2025061546:Same reporter,Different patient US-GSK-US2025061548:Same reporter,Different patient US-GSK-US2025061545:Same reporter,Different patient